These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29308349)

  • 21. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
    Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
    Cosman F; Eriksen EF; Recknor C; Miller PD; Guañabens N; Kasperk C; Papanastasiou P; Readie A; Rao H; Gasser JA; Bucci-Rechtweg C; Boonen S
    J Bone Miner Res; 2011 Mar; 26(3):503-11. PubMed ID: 20814967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia.
    Guo CY; Weetman AP; Eastell R
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):535-41. PubMed ID: 8977749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-energy extracorporeal shockwave therapy in humeral delayed and non-unions.
    Dahm F; Feichtinger X; Vallant SM; Haffner N; Schaden W; Fialka C; Mittermayr R
    Eur J Trauma Emerg Surg; 2022 Aug; 48(4):3043-3049. PubMed ID: 34515810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 25-Hydroxyvitamin-D and Bone Turnover Marker Levels in Patients with Distal Radial Fracture.
    Rozental TD; Herder LM; Walley KC; Zurakowski D; Coyle K; Bouxsein ML; Wolf JM
    J Bone Joint Surg Am; 2015 Oct; 97(20):1685-93. PubMed ID: 26491133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Extracorporeal Shockwave Therapy for the treatment of scaphoid delayed union and nonunion: a retrospective analysis examining the rate of consolidation and further outcome variables].
    Fallnhauser T; Wilhelm P; Priol A; Windhofer C
    Handchir Mikrochir Plast Chir; 2019 Jun; 51(3):164-170. PubMed ID: 31167276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do markers of bone resorption add to bone mineral density and ultrasonographic heel measurement for the prediction of hip fracture in elderly women? The EPIDOS prospective study.
    Garnero P; Dargent-Molina P; Hans D; Schott AM; Bréart G; Meunier PJ; Delmas PD
    Osteoporos Int; 1998; 8(6):563-9. PubMed ID: 10326062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracorporeal shockwave therapy shows site-specific effects in osteoarthritis of the knee in rats.
    Wang CJ; Sun YC; Siu KK; Wu CT
    J Surg Res; 2013 Aug; 183(2):612-9. PubMed ID: 23472862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in bone mass and bone turnover following tibial shaft fracture.
    Veitch SW; Findlay SC; Hamer AJ; Blumsohn A; Eastell R; Ingle BM
    Osteoporos Int; 2006; 17(3):364-72. PubMed ID: 16362144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
    Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
    J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of scaphoid waist nonunion by one, two headless compression screws or plate with or without additional extracorporeal shockwave therapy.
    Quadlbauer S; Pezzei C; Beer T; Jurkowitsch J; Keuchel T; Schlintner C; Schaden W; Hausner T; Leixnering M
    Arch Orthop Trauma Surg; 2019 Feb; 139(2):281-293. PubMed ID: 30523445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].
    Mohamed Y; Haifa H; Datel O; Fadoua HN; Smeh BH; Mahbouba J; Saoussen Z; Bejia I; Mongi T; Mohamed FN; Naceur B
    Tunis Med; 2014 May; 92(5):304-10. PubMed ID: 25504382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated Bone Turnover Markers Are Associated With Distal Radius Fractures in Premenopausal Women.
    Ting BL; Walley KC; Travison TG; Rozental TD
    J Hand Surg Am; 2017 Feb; 42(2):71-77. PubMed ID: 28160903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the acute alterations in serum bone turnover markers and bone mineral density among women with surgical menopause.
    Bahar S; Abali R; Guzel S; Bozkurt S; Guzel EC; Aral H; Boran AB
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):194-7. PubMed ID: 21764505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D and parathyroid hormone in relation to bone health in Croatian women.
    Keser I; Cvijetić S; Bituh M; Rumora Samarin I; Ilich JZ; Colić Barić I; Rumbak I
    Arch Osteoporos; 2018 Jun; 13(1):69. PubMed ID: 29936589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
    Heikkinen AM; Parviainen M; Niskanen L; Komulainen M; Tuppurainen MT; Kröger H; Saarikoski S
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2476-82. PubMed ID: 9253321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study.
    Garnero P; Munoz F; Sornay-Rendu E; Delmas PD
    Bone; 2007 Mar; 40(3):716-22. PubMed ID: 17112798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Roughly Focused Extracorporeal Shock Waves Therapy on the Expressions of Bone Morphogenetic Protein-2 and Osteoprotegerin in Osteoporotic Fracture in Rats.
    Huang HM; Li XL; Tu SQ; Chen XF; Lu CC; Jiang LH
    Chin Med J (Engl); 2016 Nov; 129(21):2567-2575. PubMed ID: 27779163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between bone mineral density and biochemical markers of bone turnover in hemodialysis patients.
    Sit D; Kadiroglu AK; Kayabasi H; Atay AE; Yilmaz Z; Yilmaz ME
    Adv Ther; 2007; 24(5):987-95. PubMed ID: 18029324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients.
    Okuno S; Inaba M; Kitatani K; Ishimura E; Yamakawa T; Nishizawa Y
    Osteoporos Int; 2005 May; 16(5):501-9. PubMed ID: 15309383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.